Novosanis

Novosanis

Foundation date

12/03/2013

Sector

#Medical Technology

Subsector

• #Medtech - Delivery devices
• #Medtech - Diagnostic devices

Therapeutic areas

• #Genitourinary system
• #Infectious and parasitic diseases

Novosanis designs and develops medical devices for a variety of applications, ranging from injection appliances to in vitro diagnostic accessories. Novosanis has two devices in its portfolio: VAX-ID, suited for injections of e.g. vaccines in the dermal layer of the skin and Colli-Pee, suited for collection of first void urine for detection of e.g. sexually transmitted infections and cancer. Novosanis aims to improve health and patient care and to offer a better quality of life through sustainable innovative technologies.